Terms: = Colorectal cancer AND AXIN2, AXIL, 8313, ENSG00000168646, MGC126582, DKFZp781B0869
165 results:
1. Identification of epigenetic silencing of the SFRP2 gene in colorectal cancer as a clinical biomarker and molecular significance.
Boughanem H; Pilo J; García-Flores LA; Arranz I; Ramos-Fernandez M; Ortega-Castan M; Crujeiras AB; Sandoval J; Macias-Gonzalez M
J Transl Med; 2024 May; 22(1):509. PubMed ID: 38802858
[TBL] [Abstract] [Full Text] [Related]
2. Antimicrobial agent chloroxylenol targets β‑catenin‑mediated Wnt signaling and exerts anticancer activity in colorectal cancer.
Sun Q; Liu B; Lan Q; Su Z; Fu Q; Wang L; Deng Y; Li C; Xue VW; Liu S; Chen X; Yang G; Lu D
Int J Oncol; 2023 Nov; 63(5):. PubMed ID: 37681484
[TBL] [Abstract] [Full Text] [Related]
3. Complete mesocolic excision for right hemicolectomy: an updated systematic review and meta-analysis.
De Lange G; Davies J; Toso C; Meurette G; Ris F; Meyer J
Tech Coloproctol; 2023 Nov; 27(11):979-993. PubMed ID: 37632643
[TBL] [Abstract] [Full Text] [Related]
4. Pharmacological targeting of axin2 suppresses cell growth and metastasis in colorectal cancer.
Cheng LZ; Huang DL; Tang ZR; Zhang JH; Xiong T; Zhou C; Zhang NX; Fu R; Cheng YX; Wu ZQ
Br J Pharmacol; 2023 Dec; 180(23):3071-3091. PubMed ID: 37461816
[TBL] [Abstract] [Full Text] [Related]
5. Single-cell response to Wnt signaling activation reveals uncoupling of Wnt target gene expression.
Söderholm S; Jauregi-Miguel A; Pagella P; Ghezzi V; Zambanini G; Nordin A; Cantù C
Exp Cell Res; 2023 Aug; 429(2):113646. PubMed ID: 37271249
[TBL] [Abstract] [Full Text] [Related]
6. Investigating the WNT/TCF pathway and the value of DCE-MRI in predicting and evaluating the efficacy of neoadjuvant radiotherapy and chemotherapy for locally advanced rectal cancer.
Cheng Q; Rong F; Ye S; Zheng B; Chen X; Ye N; Ling Q; Wu W
Cell Mol Biol (Noisy-le-grand); 2023 Feb; 69(2):95-100. PubMed ID: 37224039
[TBL] [Abstract] [Full Text] [Related]
7. ALKBH5 Drives Immune Suppression Via Targeting axin2 to Promote colorectal cancer and Is a Target for Boosting Immunotherapy.
Zhai J; Chen H; Wong CC; Peng Y; Gou H; Zhang J; Pan Y; Chen D; Lin Y; Wang S; Kang W; To KF; Chen Z; Nie Y; He HH; Sung JJ; Yu J
Gastroenterology; 2023 Aug; 165(2):445-462. PubMed ID: 37169182
[TBL] [Abstract] [Full Text] [Related]
8. Genotype-Phenotype Correlations in Autosomal Dominant and Recessive APC Mutation-Negative colorectal Adenomatous Polyposis.
Zhu LH; Dong J; Li WL; Kou ZY; Yang J
Dig Dis Sci; 2023 Jul; 68(7):2799-2810. PubMed ID: 36862359
[TBL] [Abstract] [Full Text] [Related]
9. axin2-related oligodontia-colorectal cancer syndrome with cleft palate as a possible new feature.
Roht L; Hyldebrandt HK; Stormorken AT; Nordgarden H; Sijmons RH; Bos DK; Riegert-Johnson D; Mantia-Macklin S; Ilves P; Muru K; Wojcik MH; Kahre T; Õunap K
Mol Genet Genomic Med; 2023 Jun; 11(6):e2157. PubMed ID: 36860143
[TBL] [Abstract] [Full Text] [Related]
10. Genetic Predisposition to colorectal cancer: How Many and Which Genes to Test?
Rebuzzi F; Ulivi P; Tedaldi G
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768460
[TBL] [Abstract] [Full Text] [Related]
11. Transferrin Receptor-Mediated Iron Uptake Promotes Colon Tumorigenesis.
Kim H; Villareal LB; Liu Z; Haneef M; Falcon DM; Martin DR; Lee HJ; Dame MK; Attili D; Chen Y; Varani J; Spence JR; Kovbasnjuk O; Colacino JA; Lyssiotis CA; Lin HC; Shah YM; Xue X
Adv Sci (Weinh); 2023 Apr; 10(10):e2207693. PubMed ID: 36703617
[TBL] [Abstract] [Full Text] [Related]
12. Racial/Ethnic and Sex Differences in Somatic cancer Gene Mutations among Patients with Early-Onset colorectal cancer.
Holowatyj AN; Wen W; Gibbs T; Seagle HM; Keller SR; Edwards DRV; Washington MK; Eng C; Perea J; Zheng W; Guo X
Cancer Discov; 2023 Mar; 13(3):570-579. PubMed ID: 36520636
[TBL] [Abstract] [Full Text] [Related]
13. axin2 germline testing in a French cohort validates pathogenic variants as a rare cause of predisposition to colorectal polyposis and cancer.
Leclerc J; Beaumont M; Vibert R; Pinson S; Vermaut C; Flament C; Lovecchio T; Delattre L; Demay C; Coulet F; Guillerm E; Hamzaoui N; Benusiglio PR; Brahimi A; Cornelis F; Delhomelle H; Fert-Ferrer S; Fournier BPJ; Hovnanian A; Legrand C; Lortholary A; Malka D; Petit F; Saurin JC; Lejeune S; Colas C; Buisine MP
Genes Chromosomes Cancer; 2023 Apr; 62(4):210-222. PubMed ID: 36502525
[TBL] [Abstract] [Full Text] [Related]
14. Synthesis and Cytotoxic Activity of 1,2,4-Triazolo-Linked
Yakkala PA; Panda SR; Shafi S; Naidu VGM; Yar MS; Ubanako PN; Adeyemi SA; Kumar P; Choonara YE; Radchenko EV; Palyulin VA; Kamal A
Molecules; 2022 Nov; 27(21):. PubMed ID: 36364474
[TBL] [Abstract] [Full Text] [Related]
15. Axin1 Protects Colon Carcinogenesis by an Immune-Mediated Effect.
Sanson R; Lazzara SL; Cune D; Pitasi CL; Trentesaux C; Fraudeau M; Letourneur F; Saintpierre B; Le Gall M; Bossard P; Terris B; Finetti P; Bertucci F; Mamessier E; Romagnolo B; Perret C
Cell Mol Gastroenterol Hepatol; 2023; 15(3):689-715. PubMed ID: 36356835
[TBL] [Abstract] [Full Text] [Related]
16. Construction of a colorectal cancer Prognostic Risk Model and Screening of Prognostic Risk Genes Using Machine-Learning Algorithms.
Du X; Qi H; Ji W; Li P; Hua R; Hu W; Qi F
Comput Math Methods Med; 2022; 2022():9408839. PubMed ID: 36267311
[TBL] [Abstract] [Full Text] [Related]
17. Clinicopathological and molecular characterization of deficient mismatch repair colorectal cancer.
Yamada A; Yamamoto Y; Minamiguchi S; Kamada M; Sunami T; Ohashi S; Seno H; Kawada K; Muto M
Hum Pathol; 2022 Dec; 130():1-9. PubMed ID: 36150551
[TBL] [Abstract] [Full Text] [Related]
18. Isolation and synthesis of rocaglaol derivatives by inhibiting Wnt/β-catenin and MAPK signaling pathways against colorectal cancer.
Li Y; Qiu J; Yi P; Yang J; Gu W; Li Y; Yuan C; Hao X
Bioorg Chem; 2022 Dec; 129():106149. PubMed ID: 36116324
[TBL] [Abstract] [Full Text] [Related]
19. Microsatellite instability/mismatch repair deficiency and activation of the Wnt/β-catenin signaling pathway in gastric adenocarcinoma of the fundic gland: A case report.
Yang G
Medicine (Baltimore); 2022 Aug; 101(34):e30311. PubMed ID: 36042639
[TBL] [Abstract] [Full Text] [Related]
20. Pharmacologic Manipulation of Late SV40 Factor Suppresses Wnt Signaling and Inhibits Growth of Allogeneic and Syngeneic Colon cancer Xenografts.
Lotfollahzadeh S; Lo D; York EA; Napoleon MA; Yin W; Elzinad N; Le J; Zhang M; Yang X; Morrissey A; Elsadawi M; Zhao Q; Schaus SE; Hansen U; Chitalia VC
Am J Pathol; 2022 Aug; 192(8):1167-1185. PubMed ID: 35710032
[TBL] [Abstract] [Full Text] [Related]
[Next]
